Home › Head and Neck Squamous Cell Carcinoma › NCT01473784
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patient must present with indications for diagnostic or therapeutic approaches for benign and/or malignant diseases of the oral cavity or laryngopharynx (including the neoplastic lesions of the tongue, tongue base, retromolar trigone, tonsils, palate, posterior and lateral pharynx, glottic, supraglottic and subglottic larynx) * Patients must have adequate transoral exposure of the oral cavity and laryngopharynx for TORS instrumentation * Written informed consent and/or Consent waiver by institutional review board (IRB) Exclusion Criteria: * Unexplained fever and/or untreated, active infection * Patient pregnancy * Previous head and neck surgery that would preclude transoral/robotic procedures. This is at the investigator's discretion. This is not an exclusion criterion for the non-surgical arm. * The presence of medical conditions contraindicating general anesthesia or transoral surgical approaches * Inability to grant informed consent * INTRAOPERATIVE EXCLUSION CRITERIA: * Inability to adequately visualize anatomy to perform the diagnostic or therapeutic surgical approach transorally
About the study
This pilot clinical trial studies transoral robotic surgery (TORS) in treating patients with benign or malignant tumors of the head and neck. TORS is a less invasive type of surgery for head and neck cancer and may have fewer side effects and improve recovery
What is being tested
- transoral robotic surgery (procedure)
- quality of life assessment (procedure)
Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 600 · Started: Dec 3, 2007
Contact the study team
- Ohio State University Comprehensive Cancer Center · Phone: 1-800-293-5066
Official record on ClinicalTrials.gov — NCT01473784
Locations in the U.S.
| Ohio | Ohio State University Medical Center, Columbus |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.